Ayurveda, the unlikely urban beneficiary of covid3 min read 30 Aug 2021, 12:40 PM IST
Data suggest that the demand for Ayurvedic products has spiked during the pandemic. The lack of a foolproof allopathic cure for covid-19 has boosted the appeal for immunity-boosting ‘natural’ treatments
One industry that appears to be thriving during the pandemic is Ayurveda. Dabur India reported over 50% growth in its Ayurveda business during the June-ended quarter. A recent Kantar report estimated that the immunity segment (including products such as chawanprash, honey, herbal tea) saw 38% year-on-year growth in fiscal 2021 in urban India. While covid-19 may have provided an opportunity for the Ayurveda industry, the Indian government also played an extensive role in promoting the Ayurveda economy, valued at ₹30,000 crore, according to CII estimates .
Select your Category